Histone Therapeutics
This company develops precision epigenetic reprogramming treatments focused on restoring or enhancing gene expression without altering the genetic code. Their "ON" platform uses transient mRNA delivery via non-viral vectors to precisely activate silenced or underexpressed genes. This technology aims to address diseases and aging by reprogramming the epigenome to optimize gene expression profiles.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- This company develops precision epigenetic reprogramming treatments focused on restoring or enhancing gene expression without altering the genetic code. Their "ON" platform uses transient mRNA delivery via non-viral vectors to precisely activate silenced or underexpressed genes. This technology aims to address diseases and aging by reprogramming the epigenome to optimize gene expression profiles.